Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
10 μg | Warenkorb auf Verfügbarkeit prüfen | € 612,00 |
€ 612,00
recombinant
expressed in mouse NSO cells
Quality Segment
assay
≥95% (SDS-PAGE)
form
solution
specific activity
≥1.0 EU/μg, 30,000 pmol/min-μg protein
mol wt
predicted mol wt ~60 kDa
concentration
0.4-0.6 mg/mL
impurities
≤1.0 EU/μg endotoxin
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... CES2(8824)
Biochem/physiol Actions
Physical form
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description recombinant, expressed in mouse NSO cells, ≥95% (SDS-PAGE) | description for serum, plasma and cell culture supernatants | description Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | description Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution |
| Gene Information human ... CES2(8824) | Gene Information human ... CES2(8824) | Gene Information human ... CES2(8824) | Gene Information human ... CES2(8824) |
| assay ≥95% (SDS-PAGE) | assay - | assay - | assay - |
| specific activity 30,000 pmol/min-μg protein, ≥1.0 EU/μg | specific activity - | specific activity - | specific activity - |
| form solution | form - | form buffered aqueous glycerol solution | form buffered aqueous glycerol solution |
| concentration 0.4-0.6 mg/mL | concentration - | concentration - | concentration 0.1mg/ml |
| recombinant expressed in mouse NSO cells | recombinant - | recombinant - | recombinant - |
Still not finding the right product?
Explore all of our products under Carboxylesterase 2 human
Signalwort
Danger
Gefahrencodes
Sicherheitshinweise
Hazard Classifications
Resp. Sens. 1
Lagerklasse
10 - Combustible liquids
Was ist los?
WGK 1
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.




